Search

everythinglearnresearchcommunity

for

Search:↓

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

People with lupus and rheumatoid arthritis have thinner hair than healthy people.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Hair loss was the first sign of a brain-related complication in a woman with lupus, and early treatment helped her hair grow back.

42% of SLE patients had thyroid issues, mostly hypothyroidism.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.

Effective treatment improved skin and overall symptoms in a lupus patient.

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

Older men with late-onset lupus have a higher mortality rate than women.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

Juvenile-onset lupus patients have more severe symptoms and need stronger treatment.

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Tph cells are linked to the severity of systemic lupus erythematosus.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

A risk prediction model can help diagnose systemic lupus erythematosus earlier in primary care.

Pediatric systemic lupus erythematosus is a severe autoimmune disease in children requiring early diagnosis and comprehensive management.

COVID-19 vaccination may trigger lupus in some people.

SLE is more common among Nigerians than previously thought, especially in women, requiring early treatment.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

SLE patients in eastern Saudi Arabia have a generally good prognosis despite multi-organ involvement.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Early treatment with the right dose of stem cells can reduce lupus symptoms.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

The A allele of the C2 gene increases the risk of lupus, while the G allele may protect against it.